Pedram Sendi

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Portfolio theory and cost-effectiveness analysis: a further discussion
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Value Health 7:595-601. 2004
  2. ncbi Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations
    Pedram Sendi
    Division of Health Economics, Institute for Clinical Epidemiology, Basel University Hospital, Basel, Switzerland
    Health Econ 14:643-7. 2005
  3. ncbi Optimising the performance of an outpatient setting
    Pedram Sendi
    Institute for Medical Technology Assesment, Erasmus University, Rotterdam, The Netherlands
    Swiss Med Wkly 134:44-9. 2004
  4. ncbi Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations
    Pedram Sendi
    Basel Institute for Clinical Epidemiology, Kantonspital Basel, Hebelstrasse 10, CH 4031, Basel, Switzerland
    Soc Sci Med 58:1853-5. 2004
  5. ncbi A risk-adjusted approach to comparing the return on investment in health care programs
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Int J Health Care Finance Econ 4:199-210. 2004
  6. ncbi Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure
    Pedram Sendi
    Division of Infectious Diseases and Hospital Epidemiology, Basel University Hospital, Basel, Switzerland
    PLoS ONE 2:e173. 2007
  7. ncbi Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands
    Soc Sci Med 57:2207-15. 2003
  8. ncbi Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Soc Sci Med 57:969-74. 2003
  9. ncbi When time is more than money: the allocation of time between work and leisure in HIV-infected patients
    Pedram Sendi
    Division of Infectious Diseases and Hospital Epidemiology, Basel University Hospital, Basel, Switzerland
    Soc Sci Med 64:2355-61. 2007
  10. ncbi The incorporation of income and leisure in health state valuations when the measure is silent: an empirical inquiry into the sound of silence
    Werner B F Brouwer
    Institute for Medical Technology Assessment, Erasmus MC, Rotterdam, The Netherlands
    Med Decis Making 29:503-12. 2009

Detail Information

Publications24

  1. ncbi Portfolio theory and cost-effectiveness analysis: a further discussion
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Value Health 7:595-601. 2004
    ..This approach is based on the assumption that the investment proportions are not subject to uncertainty and that the budget can be invested in toto in health-care programs...
  2. ncbi Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations
    Pedram Sendi
    Division of Health Economics, Institute for Clinical Epidemiology, Basel University Hospital, Basel, Switzerland
    Health Econ 14:643-7. 2005
    ..Our results indicate that whatever separation between costs and effects is preferred, using quality of life measures which are silent on income and leisure, leads to either double-counting or ignoring real costs or effects...
  3. ncbi Optimising the performance of an outpatient setting
    Pedram Sendi
    Institute for Medical Technology Assesment, Erasmus University, Rotterdam, The Netherlands
    Swiss Med Wkly 134:44-9. 2004
    ..The optimum mix of human resources may be determined using discrete-event simulation...
  4. ncbi Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations
    Pedram Sendi
    Basel Institute for Clinical Epidemiology, Kantonspital Basel, Hebelstrasse 10, CH 4031, Basel, Switzerland
    Soc Sci Med 58:1853-5. 2004
    ..Hence, it provides neither theoretical nor practical improvements to the proposed alternative decision rule...
  5. ncbi A risk-adjusted approach to comparing the return on investment in health care programs
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Int J Health Care Finance Econ 4:199-210. 2004
    ..We can then compare the performance of the individual programs by constructing a risk-adjusted league table of expected returns...
  6. ncbi Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure
    Pedram Sendi
    Division of Infectious Diseases and Hospital Epidemiology, Basel University Hospital, Basel, Switzerland
    PLoS ONE 2:e173. 2007
    ..We estimated the clinical effect, cost and cost-effectiveness of using GRT as compared to expert opinion in patients with antiretroviral treatment failure...
  7. ncbi Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands
    Soc Sci Med 57:2207-15. 2003
    ..This paper extends the decision rule described by Birch and Gafni (J. Health Econ. 11(3) (1992) 279) within the context of a portfolio of programs when costs and effects are uncertain and resources constrained...
  8. ncbi Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty
    Pedram Sendi
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Soc Sci Med 57:969-74. 2003
    ..g., 0.05). In case the budget is exceeded, the objective function is penalised in order to account for the opportunity costs of the additional resource requirements...
  9. ncbi When time is more than money: the allocation of time between work and leisure in HIV-infected patients
    Pedram Sendi
    Division of Infectious Diseases and Hospital Epidemiology, Basel University Hospital, Basel, Switzerland
    Soc Sci Med 64:2355-61. 2007
    ..e., wage rate), and that (ii) availability of non-labour income induces income effects, i.e. individuals demand more leisure time...
  10. ncbi The incorporation of income and leisure in health state valuations when the measure is silent: an empirical inquiry into the sound of silence
    Werner B F Brouwer
    Institute for Medical Technology Assessment, Erasmus MC, Rotterdam, The Netherlands
    Med Decis Making 29:503-12. 2009
    ....
  11. ncbi Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises
    Marieke Krol
    Department of Health Policy and Management, Erasmus University Erasmus MC, Rotterdam, The Netherlands
    Value Health 12:172-80. 2009
    ..Moreover, it tests the consequences of explicit instructions to include or exclude income effects...
  12. ncbi A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off?
    Mathew Simcock
    Division of Infectious Diseases, University Hospital Basel, Basel, Switzerland
    Antivir Ther 11:305-14. 2006
    ..To assess the impact of antiretroviral therapy optimized by genotypic antiretroviral resistance testing (GRT) on healthcare costs over a 2-year period in patients after antiretroviral treatment failure...
  13. ncbi Productivity costs in health-state valuations : does explicit instruction matter?
    Marieke Krol
    Department of Health Policy and Management, Erasmus University Erasmus MC, Rotterdam, The Netherlands
    Pharmacoeconomics 24:401-14. 2006
    ..At the moment, little is known about whether the effects of ill health on income are included in health-state valuations, and how instructions on including or excluding the effects on income influence health-state valuations...
  14. ncbi Cost-effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in hip surgery patients
    Matthias Bischof
    Institute for Clinical Epidemiology, Basel University Hospital, Basel, Switzerland
    Expert Rev Pharmacoecon Outcomes Res 6:171-80. 2006
    ....
  15. ncbi Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy
    Pedram Sendi
    Division of Health Economics, Basel Institute for Clinical Epidemiology, Basel University Hospital, Hebelstrasse 10, 3rd Floor, 4031 Basel, Switzerland
    Int J Health Care Finance Econ 8:113-21. 2008
    ....
  16. ncbi Productivity costs and determinants of productivity in HIV-infected patients
    Pedram Sendi
    Division of Infectious Diseases, Basel University Hospital, Basel, Switzerland
    Clin Ther 26:791-800. 2004
    ..Socioeconomic characteristics may influence the cost-effectiveness of health care interventions in HIV-infected patients...
  17. ncbi The HAART side of resource allocation
    Pedram Sendi
    Institute for Clinical Epidemiology and the Division of Infectious Diseases, Basel University Hospital, Basel, Switzerland
    CMAJ 169:120-1. 2003
  18. ncbi Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study
    Julian Mettler
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
    BMC Infect Dis 7:21. 2007
    ....
  19. ncbi Intranasal influenza vaccine in a working population
    Pedram Sendi
    Division of Infectious Diseases, Basel University Hospital, Basel, Switzerland
    Clin Infect Dis 38:974-80. 2004
    ..As a result of these adverse events, the intranasal vaccine was removed from the market in the fall of 2001...
  20. ncbi Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective
    Angelika Aurbach
    InForMed GmbH Outcomes Research and Health Economics, Ingolstadt, Germany
    Swiss Med Wkly 134:399-405. 2004
    ..In addition, the cost-effectiveness of ramipril in the subgroup of diabetic patients was assessed...
  21. ncbi An economic evaluation of implant treatment in edentulous patients-preliminary results
    Nicola U Zitzmann
    Clinic for Reconstructive Dentistry, University of Basel, Hebelstrasse 3, Basel CH 4056, Switzerland
    Int J Prosthodont 18:20-7. 2005
    ..The aim of this prospective study was to investigate a method of analyzing cost effectiveness in dentistry. As an example, overdenture treatment with two or four implants was compared to the conventional complete denture (CD)...
  22. ncbi Low sensitivity of ultrasonography for the early diagnosis of amebic liver abscess
    Luigia Elzi
    University Hospital Basel, Switzerland
    Am J Med 117:519-22. 2004
  23. ncbi Cost-effectiveness of a heart failure management program from the societal perspective?
    Pedram Sendi
    J Am Coll Cardiol 41:1850; author reply 1850-1. 2003
  24. ncbi Decision-analytic approach: crucial to drug development
    Pedram Sendi
    Drug Discov Today 7:24. 2002